Background-Percutaneous cardiac interventions are currently performed under x-ray guidance. Magnetic resonance imaging (MRI) has been used to guide intravascular interventions in the past, but mainly in animals. Translation of MR-guided interventions into humans has been limited by the lack of MR-compatible and safe equipment, such as MR guide wires with mechanical characteristics similar to standard guide wires. The aim of the present study was to evaluate the safety and efficacy of a newly developed MR-safe and compatible passive guide wire in aiding MR-guided cardiac interventions in a swine model and describe the 2 first-in-man solely MR-guided interventions. Methods and Results-In the preclinical trial, the new MR-compatible wire aided the performance of 20 interventions in 5 swine. These consisted of balloon dilation of nondiseased pulmonary and aortic valves, aortic arch, and branch pulmonary arteries. After ethics and regulatory authority approval, the 2 first-in-man MR-guided interventions were performed in a child and an adult, both with elements of valvar pulmonary stenosis. Catheter manipulations were monitored with real-time MRI sequence with interactive modification of imaging plane and slice position. Temporal resolution was 11 to 12 frames/s. Catheterization procedure times were 110 and 80 minutes, respectively. Both patients had successful relief of the valvar stenosis and no procedural complications. Conclusions-The described preclinical study and case reports are encouraging that with the availability of the new MR-compatible and safe guide wire, certain percutaneous cardiac interventions will become feasible to perform solely under MR guidance in the future. A clinical trial is underway in our institution. (Circ Cardiovasc Interv. 2010;3:585-592.)
D
iagnosis and treatment of patients with congenital heart disease has improved considerably over the past few decades, with more patients surviving into adulthood and more complex operations and interventions being performed across all age groups. Although cardiac anatomy and function can be easily assessed by echocardiography or magnetic resonance imaging (MRI), hemodynamic pressure measurements can only be performed invasively, mainly under x-ray guidance. However, the use of radiation during repetitive x-ray-guided catheterization has led to concerns relating to the risk of solid tumors in later life, 1, 2 and that is particularly true in children in whom increased radiosensitivity, coupled with the possibility of repetitive exposure to diagnostic and interventional x-ray procedures, can lead to a significant increase of cancer risk. 3, 4 Clinical Perspective on p 592
In contrast, MR-guided diagnostic cardiac catheterizations involve no exposure to radiation and are currently established in some centers as their preferred method for assessment of pulmonary vascular resistance in children and adults. [5] [6] [7] As well as providing hemodynamic data, MRI-guided catheterization procedures provide useful additional information, such as detailed delineation of the cardiac anatomy, flows across valves and in large vessels, pressure-volume loop relationships and ventricular function, leading to more accurate and informed treatment stratification and assessment of outcome. Furthermore, real-time visualization of the cardiovascular structures in any required spatial orientation, and more detailed additional information obtained from 3D MRI scans, can be of particular benefit in patients with complex congenital heart disease.
Although MR-guided diagnostic catheterizations are feasible without the use of a guide wire, catheter interventions nearly always require a suitable guide wire to aid and support the procedures. Standard guide wires, approved for x-ray procedures, are manufactured from nickel-titanium superelastic memory alloys (nitinol) or stainless steel. Because of the conductive properties of these materials and the length of the guide wire, radiofrequency coupling can cause significant heating of the material 8 ; hence, metallic guide wires are not applicable for MR-guided interventions in patients.
Continuous development of software and hardware has allowed the application of interventional MRI (i-MRI) in animal models for many procedures currently performed under x-ray guidance and for the in vivo monitoring of catheter-based vascular gene delivery. 9 -13 However, some of the guide wires used in these studies have not been proven to be radiofrequency-safe, 13 whereas other radiofrequency-safe polymer guide wires have not been found to conform mechanically to norms and do not provide adequate support for the interventional procedures. 12, 14 Overall, there have been no interventions in an animal model to date using a guide wire that is fully MR-compatible and radiofrequency-safe and has mechanical properties similar to the standard nitinol or stainless steel guide wires used in the x-ray cardiac catheterization laboratory. As a result, none of the above promising approaches for MRI-guided interventions had been translated so far into the clinical setting. An MR-safe guide wire with the mechanical features of a standard nitinol guide wire was developed and proposed recently. 15 This is the first guide wire that fulfils all prerequisites to become a clinical device with both actual safety proof and norm-conforming mechanical properties.
In the present study, we report the preclinical assessment of guide wire behavior when guiding and supporting MRcompatible catheters and valvuloplasty balloons for MR-guided interventions and the first-in-man MR-guided congenital cardiac interventions for 2 patients with pulmonary valve stenosis.
Methods

Instruments
Guide Wires
A nonmetallic MR-compatible and safe guide wire (MR-GW) with features, properties, and safety characteristics as described previously was used for all interventions. 15 The core of the MR-GW consists of an MR-safe glass fiber-compound and is produced using micropultrusion leading to a compound fiber with excellent flexural and torsional stiffness and improved kinking properties as compared with polyetheretherketon-based MR guide wires proposed previously. 14 A 10-cm-long, cone-shaped nitinol tip section is attached distally to provide superelasticity, higher flexibility and to allow shaping of the tip. The compound material is doped with iron at a concentration of 1% of the effective matrix mass to provide MR visibility over the full length. For accurate localization of the tip, additional tiny iron splints of 50-m diameter and 2-mm length are affixed along the distal 10 Figure 1 . Dilatation of the pulmonary valve in the swine. Images show the CO 2 -filled wedge catheter as a dark spot in the inferior vena cava (1), the right atrium (2), the right ventricle (3), and the main pulmonary artery (4, 5) . The guide wire was inserted into the catheter and advanced into the right pulmonary artery (6) . Note that the in-between distance of the inferior 3 arrows represents the 2-cm distance between the iron oxide markers. The balloon wedge catheter was exchanged for the valvuloplasty catheter and advanced to the pulmonary valve. The balloon was inflated with diluted Gd-DTPA (7 and 8, asterisk) and the pulmonary valve was dilated.
cm of the MR-GW every 2 cm and then every 5 cm for the next 30 cm. A biocompatible hydrophilic coating (Lubriteq, Hemoteq AG, Würselen, Germany) covers the jacket to reduce blood clotting and to ensure proper gliding within catheters and vessels. The diameter of the MR-GW is 0.032 inches and comes in different lengths of 200 to 300 cm.
Catheters
Balloon wedge pressure catheters (Arrow, Reading, Pa) were used for right and left heart catheterization and to approach the target lesions. The balloon of the wedge catheter was filled with CO 2 and was passively visualized as a dark circular signal void in the bright blood pool on the steady-state free precession images. 16 Commercially available, MR-compatible valvuloplasty catheters (Tyshak II, NuMED, Hopkington, NY) were used for balloon dilation of the great arterial valves, aortic arch, and branch pulmonary arteries.
Preclinical Animal Study
Five female domestic pigs were included, as approved by the government committee on animal experiments. All interventions were carried out under general anesthesia at the University Hospital Aachen, Germany. The new MR-GW was used to aid balloon dilation of nondiseased pulmonary and aortic valves, aortic arch, and branch pulmonary arteries. Each procedure was carried out twice in each animal and performed by 2 different operators of a group of 3 experienced interventionalists (A.T., G.K., and R.R.). Invasive pressure monitoring was not performed because there were no stenotic lesions, and the main interest of the study was to assess the behavior of the guide wire.
All interventions were performed on a clinical 1.5-T interventional MR system (Achieva, Philips, Best, The Netherlands). Interactive real-time MR scanning was used to monitor the motion of the devices.
For right heart catheterization, the balloon wedge pressure catheter was advanced into the inferior vena cava and inflated with 1.25 mL of CO 2 , making it clearly visible as a dark signal void within the surrounding bright blood (Figure 1) . The catheter was then advanced to the right ventricle (RV), main pulmonary artery (MPA), and right pulmonary artery, and the wire was introduced. The different spacing of the iron splints on the wire allowed visual assessment of the wire length into the branch pulmonary artery ( Figure 1 ). The balloon valvuloplasty catheter was introduced over the wire. To increase its visibility and facilitate correct positioning 1 mL of Gd-DTPA (Magnevist, Beyer-Schering, Berlin, Germany) diluted in saline (1:10) was injected into the balloon. After placing it across the pulmonary valve, it was manually inflated up to 2 atm and the pressure maintained for 5 seconds. With the wire in a stable position wedged into one of the pulmonary arteries, the valvuloplasty catheter was advanced into a branch pulmonary artery and balloon dilation was performed.
For left heart catheterization the balloon wedge pressure catheter was first advanced into the descending aorta ( Figure 2 ). The tip of the guide wire was shaped to a hook configuration and the guide wire advanced via the catheter into the aortic arch. Subsequently, the catheter and the guide wire were advanced into the ascending aorta and the aortic valve was crossed. The balloon valvuloplasty catheter was manually inflated with diluted Gd-DTPA at a sustained pressure for 5 seconds. With the wire in a stable position in the left ventricle, the valvuloplasty balloon was withdrawn to a level distal to the left subclavian artery, and balloon dilation of the aortic arch was performed ( Figure 2 ).
Clinical First-in-Man Congenital Cardiac Interventions
Ethical approval for the performance of MRI-guided interventions for adults and children with congenital heart disease was obtained by an expert United Kingdom-based device research ethics committee. Inclusion criteria for patient participation in the clinical trial were simple congenital intervention, such as pulmonary or aortic valvuloplasty, ballooning of branch pulmonary artery or aortic arch or preimplanted stents in the above positions, and age Ͼ2 years old. The new MR-GW was assessed and approved by the UK Medicines and Healthcare Products Regulatory Agency. The first-in-man procedures were performed at the Evelina Children's Hospital, St Thomas' Hospital, London, United Kingdom. The procedures were performed under general anesthesia, as per our routine practice for such congenital cardiac interventions in our hospital.
Two patients with pulmonary valve stenosis underwent MRguided balloon dilation of their pulmonary valves. The first patient was a 6-year-old boy, who had progression of valvar pulmonary stenosis with peak echocardiographic gradient of 63 mm Hg. After informed consent, the parents opted for the MR-guided interventional study. The second patient was a 43-year-old man with valvar and subvalvar pulmonary stenosis and severe right ventricular hypertrophy. Doppler echocardiography revealed double envelope, indicating both valvar and subvalvar pulmonary stenosis and a peak gradient of 110 mm Hg. Both patients had an intact septum, were fully saturated, and were clinically asymptomatic.
The procedures were performed on an interventional 1.5-T MRscanner (Achieva, Philips, Best, The Netherlands) in our combined x-ray /MRI laboratory with the x-ray equipment readily available for emergency bailout if required. We used the commercially available hemodynamic monitoring system EP Tracer 102 (CardioTek B.V, Maastricht, Holland) for hemodynamic pressure monitoring. The hemodynamic traces were displayed on 1 of the 2 panels in the mini in-room console, with the other panel displaying the i-MRI sequences. The operator could start and stop the interactive scanning independently using foot pedals, which also facilitated the adjustment of the imaging plane and slice position to get the interventional devices in view.
Cannulation of the femoral vessels was performed at the beginning of the procedure and the patient was moved into the MRI scanner. For both patients, the same scan protocol with similar scan parameters were used (Table) , except for a higher spatial resolution used in the pediatric case. After a plan-scan and sense reference scan, 2D steady-state free precession cine MRI sequences were performed to assess the valve lesion. An ECG-triggered, free-breathing 3D SSFP scan and 2D quantitative phase-contrast flow scans (Table) were used to measure the lesion size and maximum flow velocity through the lesion.
The common imaging planes for catheter guidance were identified and stored. Balloon visualization was facilitated with injection of Endorem 5% (for the adult patient) and dilute Gadolinium 1:10 (for the pediatric patient) into the balloon lumen. Cine and phase-contrast flow images were repeated after the intervention to assess the hemodynamic result.
Results
Clinical Case 1 (Pediatric)
MRI assessment of the pulmonary valve revealed bicuspid pulmonary valve with diameter of 22ϫ22 mm and effective orifice area of 49 mm 2 . A 6F wedge catheter was used for right heart catheterization and to cross the pulmonary valve. Baseline hemodynamic gradient between the RV and MPA was 44 mm Hg. The wedge catheter was advanced to the distal left pulmonary artery (LPA) and the MR wire was introduced through the catheter to the distal vasculature and visualized on the sagittal view with the iron splints easily visible. We observed no artifacts caused by the iron markers on the wire. A 22-mm Tyshak balloon was initially used and inflated for 5 seconds. The waist seen on it was completely abolished (Figure 3 ). Repeat pressure measurement revealed mild gradient improvement to 30 mm Hg; hence, a 25-mm Tyshak II balloon was inflated across the valve as done previously. Repeat gradient assessment showed further improvement to 25 mm Hg. No further attempts on inflating the pulmonary valve with a bigger balloon were made because of the bicuspid nature of the valve and the fact that balloons bigger that 25 mm would be inappropriately big for a child of this age. Repeat cine MRI assessment revealed increase of the effective orifice area on of the pulmonary valve from 49 to 92 mm 2 . Phase-contrast flow images showed no valvar regurgitation before and mild valvar regurgitation after the procedure (regurgitant fraction of 7%). The total catheterization time was 110 minutes and total procedure time, including the preprocedure and postprocedure MRI, was 200 minutes.
The procedure was well tolerated by the patient who was woken up immediately after and was transferred to the cardiac ward 30 minutes later. Peak echocardiographic gradient as assessed the following morning had improved from 63 mm Hg before the procedure to 22 mm Hg after the procedure and the patient was discharged home a few hours later, uneventfully.
Clinical Case 2 (Adult)
The patient had known valvar and subvalvar pulmonary stenosis; hence, it was decided to alleviate the valvar component and reassess the subvalvar gradient at later stage. MRI assessment of the pulmonary valve revealed valve diameter of 21ϫ24 mm. In-plane phase-contrast flow images showed maximum velocity across the pulmonary valve and the subvalvar lesion of 3.1 m/s and 2.3 m/s, respectively. A 6F wedge catheter was used. The catheter was advanced into the LPA and then into the LPA wedge position. The MRcompatible guide wire was advanced through it and its position was confirmed on the LPA saggital view, where the iron markers were easily visible. The catheter was then withdrawn and a 23 mm Tyshak II balloon was advanced over it. Visualization of the balloon was achieved with injection of 1 mL of 5% Endorem in the balloon lumen. After correct positioning was confirmed, a full inflation was performed on the saggital RV outflow tract view (Figure 4 and video). Repeat pressure measurement did not reveal significant hemodynamic improvement; hence, a 25-mm Tyshak balloon was chosen and inflated across the pulmonary valve. RV pressure at the end of the procedure remained systemic because of infundibular collapse, as evidenced on the hemodynamic trace and the phase-contrast flow images. Velocity across the valve and subvalvar lesion was 2.5 m/s and 2.6 m/s, respectively. Gradual pullback from the MPA to beneath the pulmonary valve and then to the RV revealed a gradient of 17 mm Hg across the pulmonary valve and 60 mm Hg across the infundibular stenosis, confirming our initial suspicions that a significant subvalvar component was going to be present at the end of the procedure. The total catheterization time was 80 minutes and total procedure time with the preprocedure and postprocedure MRI was 170 minutes. (2) , and the left pulmonary artery on the saggital view (3). The course of the guide wire with its iron markers is seen on the saggital view of the IVC/RA junction (4) and from the RV into the left pulmonary artery (5). The valvuloplasty balloon was inflated with 5% Endorem (6, asterisk) and the pulmonary valve was dilated. Peak echocardiographic gradient before the procedure was 110 mm Hg with double-envelope trace (indicating valvar and subvalvar stenosis), which improved to 70 mm Hg after the procedure with change of the Doppler pattern from double to single envelope. The patient was commenced on ␤-blockade with propranolol, in an attempt to induce infundibular relaxation, until such time that the RV hypertrophy regressed sufficiently as a response to the valvar stenosis relief. No complications were noted and he was discharged home the following day. Repeat echocardiography 2 months after the procedure revealed further RV outflow tract gradient reduction to 45 mm Hg.
Discussion
Since 2001, there have been a number of animal studies showing the safety and efficacy of i-MRI for a multitude of procedures that are currently performed under x-ray guidance.
In particular, animal i-MRI has been used to facilitate procedures such as creation or closure of atrial septal communications, 11, [17] [18] [19] intracoronary imaging as well as coronary and carotid artery interventions, 9,12,20 -24 stenting of pulmonary arteries, 25 aortic coarctation, 26, 27 and vena cava interventions. 28, 29 The procedures have been aided by the use of non-MR-safe active guide wires and prototype or commercially available devices and were either solely MR-guided or combined with conventional catheterization before and after the procedure.
Active guide wires are tracked or visualized by using miniature radiofrequency coils or loopless antenna both connected to the scanner using a long metallic wire. This long wire can heat up to 70°C owing to resonating radiofrequency waves. New strategies for safe active devices have been proposed including optical transmission and use of transformers to shorten the length of the conducting wire 30, 31 ; however, no safe active guide wires have been developed so far. Semiactive catheters use tuned fiducial markers that produce increase MR signal locally without wires connecting to the scanner. 32 There are, however, issues with miniaturization and the ability to firmly secure these markers to catheters. Passive guide wires have the advantage of no risk of heating, but the disadvantage of being less visible than active guide wires and requiring manual tracking and changing of the imaging plane to keep the wire in view.
MRI-guided cardiac interventions have also been performed without the use of a guide wire in an animal model for transcatheter implantation of a prosthetic valve in the aortic valve position 33 and in patients who underwent balloon dilation of aortic coarctation, using a self-made nonmetallic guide wire that was advanced just up to the distal port of the balloon catheter. 34 Translation of the animal MR-guided interventions in humans had not been made possible to date because of the lack of fully MR-compatible equipment. An MR-safe guide wire fulfilling all prerequisites to become a clinical device has been recently developed. As a preclinical step, we used this guide wire in combination with already available MRIsafe catheters to perform solely MR-guided cardiac interventions in an animal model, and then we performed the 2 first-in-man congenital cardiac interventions. The interactive scanning parameters were optimized to improve temporal resolution to 11 to 12 frames/s (Table) . Similar frame rates are used for x-ray fluoroscopy in other institutions, particularly in longer procedures as a way of reducing x-ray radiation dose. We used an 8-to 10-mm-thick imaging slice; hence, the iron oxide markers within that slice were easily visualized. For the part of the wire outside that imaging slice, we manually moved left and right of the current imaging slice by using the foot pedals while the wire position was kept constant. During manipulation of catheters and balloons over the wire, a key imaging slice, which showed most of its length, was imaged in real time with particular attention being paid to the iron oxide marker to ensure wire stability. During the balloon dilation, we could visualize the valve and subvalvar area as well as the pulmonary artery, whereas under x-ray we would only see the balloon; hence, structural visualization was much superior compared with x-ray.
Our first patient had a bicuspid pulmonary valve, a very rare congenital entity encountered in only 0.05% to 0.1% of the population. [35] [36] [37] Although complete abolition of the balloon waist was achieved, there was still some residual pulmonary stenosis gradient at the end of the procedure, which was attributed to the bicuspid nature of the valve. The patient's hemodynamic gradient was reduced by 43% and his peak echocardiographic gradient by Ͼ60%. Our second patient was complicated by dual pathology with valvar and subvalvar pulmonary stenosis. Hemodynamic and MRI assessment at the end of the MR catheterization procedure revealed that the valvar gradient was now negligible. On echocardiography, the RV outflow tract gradient decreased by 60%. In both patients we deliberately undersized the balloon, which should have been 120% to 150% of the pulmonary valve annulus, because the interventions were the first 2 in the trial; hence, a more conservative approach was followed. The contrast material used to facilitate better visualization of the valvuloplasty balloon differed between the pediatric and the adult cases. This was because the iron oxide agent Endorem, which would have been our preferred choice across all ages because of its superior visualization properties, is not currently licensed for children and we would only use it in patients Ͼ18 years of age. Endorem is used in adults for MR imaging of the liver. The intravascular dose used in these patients is 0.075 mL/kg of the 0.2 mmol/mL concentration. If Endorem was to be used for liver imaging in our adult patient who weighed 60 kg, the recommended dose would have been 4.5 mL. We used an Endorem concentration of 5%, and the absolute dose of 1 mL; hence, even if the balloon burst, the total dose of Endorem that would reach the circulation would have been well below the dose that is used in clinical practice.
We have been encouraged by the successful outcome of our first 2 clinical cases, but we must evaluate the feasibility, safety, and efficacy of the MR-guided interventions further. To this end, a clinical trial on MR-guided cardiac interventions for commonly encountered lesions, such as aortic and pulmonary valve stenosis, branch pulmonary artery or aortic arch stenosis, or dilatation of stents previously implanted in those vessels is ongoing. A committee has been set up to assess the safety and clinical outcome of the interventions. We hope that in the future MR-guided interventions will replace some cardiac catheterization procedures performed in patients with congenital heart disease. The option of performing such interventions in the MRI suite is particularly appealing because of the lack of radiation, additional physiological data obtained, and soft tissue characterization. The latter is of particular relevance in interventional procedures, because real time i-MRI is hoped to offer early recognition and response to complications such as vascular rupture 27 or impending cardiac tamponade, 38 even though clinically this is yet to be proven.
Limitations
The study is small, but a clinical trial is underway. The catheterization procedure times were long and the performance of an MRI before and after the intervention has added significantly to that time. We hope that the procedure time will shorten after our initial learning curve. The spatial and temporal resolution was acceptable to the operators in this study, but we are working on further improving it for future interventions.
Conclusion
We have demonstrated the feasibility of MRI-guided cardiac interventions using an MR-compatible guide wire. Future study is needed to determine whether the outcomes for MR-guided procedures are comparable to those guided by fluoroscopy.
